{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T10:41:22Z","timestamp":1759228882497,"version":"3.37.3"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T00:00:00Z","timestamp":1596758400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T00:00:00Z","timestamp":1596758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s11010-020-03872-x","type":"journal-article","created":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T10:03:03Z","timestamp":1596794583000},"page":"195-203","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Soluble recombinant human thrombomodulin suppresses inflammation-induced gastrointestinal tumor growth in a murine peritonitis model"],"prefix":"10.1007","volume":"475","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1155-1444","authenticated-orcid":false,"given":"En","family":"AMADA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumasa","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6165-5105","authenticated-orcid":false,"given":"Koshi","family":"Kumagai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Kawakubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Kitagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,7]]},"reference":[{"issue":"5","key":"3872_CR1","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1245\/s10434-012-2720-9","volume":"20","author":"M Tokunaga","year":"2013","unstructured":"Tokunaga M, Tanizawa Y, Bando E, Kawamura T, Terashima M (2013) Poor survival rate in patients with postoperative intra-abdominal infectious complications following curative gastrectomy for gastric cancer. Ann Surg Oncol 20(5):1575\u20131583","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"3872_CR2","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1097\/SLA.0000000000001828","volume":"265","author":"K Kataoka","year":"2017","unstructured":"Kataoka K, Takeuchi H, Mizusawa J, Igaki H, Ozawa S, Abe T et al (2017) Prognostic impact of postoperative morbidity after esophagectomy for esophageal cancer: exploratory analysis of JCOG9907. Ann Surg 265(6):1152\u20131157","journal-title":"Ann Surg"},{"issue":"5","key":"3872_CR3","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1093\/bja\/aew316","volume":"117","author":"International Surgical Outcomes Study Group","year":"2016","unstructured":"International Surgical Outcomes Study Group (2016) Global patient outcomes after elective surgery: prospective cohort study in 27 low-, middle- and high-income countries. Br J Anaesth 117(5):601\u2013609","journal-title":"Br J Anaesth"},{"issue":"5","key":"3872_CR4","first-page":"307","volume":"13","author":"TR Vogel","year":"2012","unstructured":"Vogel TR, Dombrovskiy VY, Lowry SF (2012) Impact of infectious complications after elective surgery on hospital readmission and late deaths in the US. Medicare Popul 13(5):307\u2013311","journal-title":"Medicare Popul"},{"issue":"6","key":"3872_CR5","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.imbio.2011.10.019","volume":"217","author":"AR Novotny","year":"2012","unstructured":"Novotny AR, Reim D, Assfalg V, Altmayr F, Friess HM, Emmanuel K et al (2012) Mixed antagonist response and sepsis severity-dependent dysbalance of pro- and anti-inflammatory responses at the onset of postoperative sepsis. Immunobiology 217(6):616\u2013621","journal-title":"Immunobiology"},{"issue":"8","key":"3872_CR6","doi-asserted-by":"publisher","first-page":"911","DOI":"10.2217\/imt.11.79","volume":"3","author":"W Chen","year":"2011","unstructured":"Chen W (2011) Tregs in immunotherapy: opportunities and challenges. Immunotherapy 3(8):911\u2013914","journal-title":"Immunotherapy"},{"issue":"11","key":"3872_CR7","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/nrc3611","volume":"13","author":"E Elinav","year":"2013","unstructured":"Elinav E, Nowarski R, Thaiss CA, Hu B, Jin C, Flavell RA (2013) Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer 13(11):759\u2013771","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"3872_CR8","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/nrd1854","volume":"4","author":"JA Buras","year":"2005","unstructured":"Buras JA, Holzmann B, Sitkovsky M (2005) Animal models of sepsis: setting the stage. Nat Rev Drug Discov 4(10):854\u2013865","journal-title":"Nat Rev Drug Discov"},{"key":"3872_CR9","first-page":"e2860","volume":"51","author":"MG Toscano","year":"2011","unstructured":"Toscano MG, Ganea D, Gamero AM (2011) Cecal ligation puncture procedure. J Vis Exp 51:e2860","journal-title":"J Vis Exp"},{"issue":"2","key":"3872_CR10","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-4804(80)90037-2","volume":"29","author":"KA Wichterman","year":"1980","unstructured":"Wichterman KA, Baue AE, Chaudry IH (1980) Sepsis and septic shock\u2014a review of laboratory models and a proposal. J Surg Res 29(2):189\u2013201","journal-title":"J Surg Res"},{"issue":"5","key":"3872_CR11","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/SHK.0b013e3181cc064b","volume":"33","author":"K Suda","year":"2010","unstructured":"Suda K, Takeuchi H, Hagiwara T, Miyasho T, Okamoto M, Kawasako K et al (2010) Neutrophil elastase inhibitor improves survival of rats with clinically relevant sepsis. Shock 33(5):526\u2013531","journal-title":"Shock"},{"issue":"9","key":"3872_CR12","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1007\/s00268-005-0369-2","volume":"30","author":"K Suda","year":"2006","unstructured":"Suda K, Kitagawa Y, Ozawa S, Saikawa Y, Ueda M, Ebina M et al (2006) Anti-high-mobility group box chromosomal protein 1 antibodies improve survival of rats with sepsis. World J Surg 30(9):1755\u20131762","journal-title":"World J Surg"},{"issue":"1\u20132","key":"3872_CR13","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0304-3835(99)00348-1","volume":"149","author":"H Ogawa","year":"2000","unstructured":"Ogawa H, Yonezawa S, Maruyama I, Matsushita Y, Tezuka Y, Toyoyama H et al (2000) Expression of thrombomodulin in squamous cell carcinoma of the lung: its relationship to lymph node metastasis and prognosis of the patients. Cancer Lett 149(1\u20132):95\u2013103","journal-title":"Cancer Lett"},{"issue":"9","key":"3872_CR14","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1038\/sj.bjc.6603098","volume":"94","author":"AM Hanly","year":"2006","unstructured":"Hanly AM, Redmond M, Winter DC, Brophy S, Deasy JM, Bouchier-Hayes DJ et al (2006) Thrombomodulin expression in colorectal carcinoma is protective and correlates with survival. Br J Cancer 94(9):1320\u20131325","journal-title":"Br J Cancer"},{"issue":"2","key":"3872_CR15","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1667\/RR14408.1","volume":"186","author":"R Pathak","year":"2016","unstructured":"Pathak R, Wang J, Garg S, Aykin-Burns N, Petersen KU, Hauer-Jensen M (2016) Recombinant thrombomodulin (Solulin) ameliorates early intestinal radiation toxicity in a preclinical rat model. Radiat Res 186(2):112\u2013120","journal-title":"Radiat Res"},{"issue":"6","key":"3872_CR16","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/j.thromres.2015.03.026","volume":"135","author":"N Akita","year":"2015","unstructured":"Akita N, Ma N, Okamoto T, Asanuma K, Yoshida K, Nishioka J et al (2015) Host protein C inhibitor inhibits tumor growth, but promotes tumor metastasis, which is closely correlated with hypercoagulability. Thromb Res 135(6):1203\u20131208","journal-title":"Thromb Res"},{"issue":"11","key":"3872_CR17","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.2215\/CJN.06620714","volume":"10","author":"BM Hall","year":"2015","unstructured":"Hall BM (2015) T cells: soldiers and spies\u2014the surveillance and control of effector T cells by regulatory T cells. Clin J Am Soc Nephrol 10(11):2050\u20132064","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"3872_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1006\/taap.1997.8218","volume":"146","author":"GF Gerberick","year":"1997","unstructured":"Gerberick GF, Cruse LW, Miller CM, Sikorski EE, Ridder GM (1997) Selective modulation of T cell memory markers CD62L and CD44 on murine draining lymph node cells following allergen and irritant treatment. Toxicol Appl Pharmacol 146(1):1\u201310","journal-title":"Toxicol Appl Pharmacol"},{"issue":"8","key":"3872_CR19","doi-asserted-by":"publisher","first-page":"3665","DOI":"10.4049\/jimmunol.1402898","volume":"195","author":"P Hsu","year":"2015","unstructured":"Hsu P, Santner-Nanan B, Hu M, Skarratt K, Lee CH, Stormon M et al (2015) IL-10 Potentiates differentiation of human induced regulatory T cells via STAT3 and Foxo1. J Immunol 195(8):3665\u20133674","journal-title":"J Immunol"},{"key":"3872_CR20","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.trim.2017.06.003","volume":"43\u201344","author":"BM Hall","year":"2017","unstructured":"Hall BM, Plain KM, Tran GT, Verma ND, Robinson CM, Nomura M et al (2017) Cytokines affecting CD4(+)T regulatory cells in transplant tolerance. III. Interleukin-5 (IL-5) promotes survival of alloantigen-specific CD4(+) T regulatory cells. Transpl Immunol 43\u201344:33\u201341","journal-title":"Transpl Immunol"},{"issue":"5 Suppl","key":"3872_CR21","doi-asserted-by":"publisher","first-page":"S288","DOI":"10.1097\/00003246-200205001-00019","volume":"30","author":"DE Joyce","year":"2002","unstructured":"Joyce DE, Grinnell BW (2002) Recombinant human activated protein C attenuates the inflammatory response in endothelium and monocytes by modulating nuclear factor-kappaB. Crit Care Med 30(5 Suppl):S288\u2013S293","journal-title":"Crit Care Med"},{"issue":"1","key":"3872_CR22","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s00281-011-0284-6","volume":"34","author":"CT Esmon","year":"2012","unstructured":"Esmon CT (2012) Protein C anticoagulant system\u2013anti-inflammatory effects. Semin Immunopathol 34(1):127\u2013132","journal-title":"Semin Immunopathol"},{"issue":"1","key":"3872_CR23","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nri1995","volume":"7","author":"H Yu","year":"2007","unstructured":"Yu H, Kortylewski M, Pardoll D (2007) Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment. Nat Rev Immunol 7(1):41\u201351","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"3872_CR24","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/scrt32","volume":"1","author":"M Rodrigues","year":"2010","unstructured":"Rodrigues M, Griffith LG, Wells AJSCR (2010) Growth factor regulation of proliferation and survival of multipotential stromal cells. Stem Cells Res Ther 1(4):32","journal-title":"Stem Cells Res Ther"},{"issue":"12","key":"3872_CR25","doi-asserted-by":"publisher","first-page":"5006","DOI":"10.1096\/fj.15-273987","volume":"29","author":"C-R Lin","year":"2015","unstructured":"Lin C-R, Wei T-YW, Tsai H-Y, Wu Y-T, Wu P-Y, Chen S-T (2015) Glycosylation-dependent interaction between CD69 and S100A8\/S100A9 complex is required for regulatory T-cell differentiation. The FASEB J 29(12):5006\u20135017","journal-title":"The FASEB J"},{"issue":"5","key":"3872_CR26","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1002\/jcb.20458","volume":"95","author":"M Davies","year":"2005","unstructured":"Davies M, Robinson M, Smith E, Huntley S, Prime S, Paterson I (2005) Induction of an epithelial to mesenchymal transition in human immortal and malignant keratinocytes by TGF-beta1 involves MAPK, Smad and AP-1 signalling pathways. J Cell Biochem 95(5):918\u2013931","journal-title":"J Cell Biochem"},{"issue":"51","key":"3872_CR27","doi-asserted-by":"publisher","first-page":"49815","DOI":"10.1074\/jbc.C200543200","volume":"277","author":"G Sandusky","year":"2002","unstructured":"Sandusky G, Berg DT, Richardson MA, Myers L, Grinnell BW (2002) Modulation of thrombomodulin-dependent activation of human protein C through differential expression of endothelial Smads. J Biol Chem 277(51):49815\u201349819","journal-title":"J Biol Chem"},{"issue":"4","key":"3872_CR28","doi-asserted-by":"publisher","first-page":"e0231003","DOI":"10.1371\/journal.pone.0231003","volume":"15","author":"S Yu","year":"2020","unstructured":"Yu S, Wang Y, Hou J, Li W, Wang X, Xiang L et al (2020) Tumor-infiltrating immune cells in hepatocellular carcinoma: Tregs is correlated with poor overall survival. PLoS ONE 15(4):e0231003","journal-title":"PLoS ONE"},{"key":"3872_CR29","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1016\/B978-0-323-35762-3.00126-8","volume-title":"Hematology","author":"K Brummel-Ziedins","year":"2018","unstructured":"Brummel-Ziedins K, Mann KG (2018) Chapter 126\u2014molecular basis of blood coagulation. In: Hoffman R, Benz EJ, Silberstein LE, Heslop HE, Weitz JI, Anastasi J, et al. (eds) Hematology, 7th edn. Elsevier, New York, pp 1885\u20131905","edition":"7"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-020-03872-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-020-03872-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-020-03872-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T23:40:14Z","timestamp":1628293214000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-020-03872-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,7]]},"references-count":29,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["3872"],"URL":"https:\/\/doi.org\/10.1007\/s11010-020-03872-x","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"type":"print","value":"0300-8177"},{"type":"electronic","value":"1573-4919"}],"subject":[],"published":{"date-parts":[[2020,8,7]]},"assertion":[{"value":"18 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"En Amada, Kazumasa Fukuda, Koshi Kumagai and Hirofumi Kawakubo declared no potential conflicts of interest with respect to the research, authorship, or publication of this article. Yuko Kitagawa has received compound of recombinant thrombomodulin (rTM) from Asahi Kasei Pharma, Tokyo, Japan.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All animal procedures were conducted in accordance with Institutional Guidelines on Animal Experimentation of Keio University and were approved by the ethics committee (approval number: 18077-(0)). All staff that participated in the study received special training in animal care and handling from the Laboratory Animal Center of Keio University of Medicine.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}